168 related articles for article (PubMed ID: 16935474)
1. Proteasomal degradation regulates expression of porphobilinogen deaminase (PBGD) mutants of acute intermittent porphyria.
Grünberg-Etkovitz N; Greenbaum L; Grinblat B; Malik Z
Biochim Biophys Acta; 2006 Sep; 1762(9):819-27. PubMed ID: 16935474
[TBL] [Abstract][Full Text] [Related]
2. Acute intermittent porphyria: expression of mutant and wild-type porphobilinogen deaminase in COS-1 cells.
Mustajoki S; Laine M; Lahtela M; Mustajoki P; Peltonen L; Kauppinen R
Mol Med; 2000 Aug; 6(8):670-9. PubMed ID: 11055586
[TBL] [Abstract][Full Text] [Related]
3. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria.
Yin Z; Wahlin S; Ellis EC; Harper P; Ericzon BG; Nowak G
Cell Transplant; 2014; 23(9):1153-62. PubMed ID: 23582197
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria.
Johansson A; Nowak G; Möller C; Blomberg P; Harper P
Mol Ther; 2004 Aug; 10(2):337-43. PubMed ID: 15294180
[TBL] [Abstract][Full Text] [Related]
6. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
[TBL] [Abstract][Full Text] [Related]
7. Regulation of porphyrin synthesis and photodynamic therapy in heavy metal intoxication.
Grinblat B; Pour N; Malik Z
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):145-58. PubMed ID: 16566714
[TBL] [Abstract][Full Text] [Related]
8. The centrality of PBGD expression levels on ALA-PDT efficacy.
Schauder A; Feuerstein T; Malik Z
Photochem Photobiol Sci; 2011 Aug; 10(8):1310-7. PubMed ID: 21655622
[TBL] [Abstract][Full Text] [Related]
9. Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice.
Unzu C; Sampedro A; Mauleón I; González-Aparicio M; Enríquez de Salamanca R; Prieto J; Aragón T; Fontanellas A
Hum Mol Genet; 2013 Jul; 22(14):2929-40. PubMed ID: 23562909
[TBL] [Abstract][Full Text] [Related]
10. Correction of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene delivery.
Johansson A; Möller C; Harper P
Mol Cell Biochem; 2003 Aug; 250(1-2):65-71. PubMed ID: 12962144
[TBL] [Abstract][Full Text] [Related]
11. Effect of delta-aminolevulinic acid on protoporphyrin IX accumulation in tumor cells transfected with plasmids containing porphobilinogen deaminase DNA.
Hilf R; Havens JJ; Gibson SL
Photochem Photobiol; 1999 Sep; 70(3):334-40. PubMed ID: 10483361
[TBL] [Abstract][Full Text] [Related]
12. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
[TBL] [Abstract][Full Text] [Related]
13. [Three new mutations in the porphobilinogen deaminase gene, detected in acute intermittent porphyria patients from Russia].
Surin VL; Luk'ianenko AV; Karpova IV; Misiurin AV; Pustovot IaS; Pivnik AV
Genetika; 2001 May; 37(5):690-7. PubMed ID: 11436563
[TBL] [Abstract][Full Text] [Related]
14. May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population.
Hrdinka M; Puy H; Martasek P
Physiol Res; 2006; 55 Suppl 2():S119-136. PubMed ID: 17298216
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic study of acute intermittent porphyria in Russia: mutation analysis and functional polymorphism search in porphobilinogen deaminase gene].
Surin VL; Luchinina IuA; Selivanova DS; Pustovoĭt IaS; Karpova IS; Pivnik AV; Luk'ianenko AV; Kravchenko SK
Genetika; 2010 Apr; 46(4):540-52. PubMed ID: 20536026
[TBL] [Abstract][Full Text] [Related]
16. Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria.
Johansson A; Nowak G; Möller C; Harper P
Mol Genet Metab; 2004 May; 82(1):20-6. PubMed ID: 15110317
[TBL] [Abstract][Full Text] [Related]
17. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.
Lindberg RL; Porcher C; Grandchamp B; Ledermann B; Bürki K; Brandner S; Aguzzi A; Meyer UA
Nat Genet; 1996 Feb; 12(2):195-9. PubMed ID: 8563760
[TBL] [Abstract][Full Text] [Related]
18. Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency.
Collantes M; Serrano-Mendioroz I; Benito M; Molinet-Dronda F; Delgado M; Vinaixa M; Sampedro A; Enríquez de Salamanca R; Prieto E; Pozo MA; Peñuelas I; Corrales FJ; Barajas M; Fontanellas A
Hum Mol Genet; 2016 Apr; 25(7):1318-27. PubMed ID: 26908609
[TBL] [Abstract][Full Text] [Related]
19. Structural insight into acute intermittent porphyria.
Song G; Li Y; Cheng C; Zhao Y; Gao A; Zhang R; Joachimiak A; Shaw N; Liu ZJ
FASEB J; 2009 Feb; 23(2):396-404. PubMed ID: 18936296
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.
Johansson A; Möller C; Fogh J; Harper P
Mol Med; 2003; 9(9-12):193-9. PubMed ID: 15208740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
